申请人:Neurocrine Biosciences, Inc.
公开号:US20220409592A1
公开(公告)日:2022-12-29
Compounds are provided herein, as well as related preparations, compositions and methods for treating diseases and/or disorders that would benefit from the same such as congenital adrenal hyperplasia (CAH).